| 08:30 – 10:05 Session I | ||
| 08:30 | M. Laube | Back-to-basics I: C-11 and/or F-18 radiochemistry – recent developments |
| 09:15 | M-A. Karageorgou | OP01 99mTc-labeled dual-modality contrast agent: from radiosynthesis to in vivo gamma-camera/MR imaging applications in mice models |
| 09:27 | A. Stankovic | OP02 Combined radionuclide and hyperthermia cancer therapy with superparamagnetic iron oxide nanoparticles coupled to 131I-labeled antibodies |
| 09:39 | G. Aleshin | OP03 Conjugates of Cerium Dioxide Nanoparticles with Macrocyclic Ligands For Radiopharmaceuticals: In Vitro And In Vivo Stability |
| 09:51 | M. T. Martinez Martinez | OP04 Dual labeling of 67Ga-DTPA-FITC-Silk Fibroin Nanoparticles for Biodistribution Studies. Optimization of the radiolabeling approach. |
10:05 – Coffee Break
| 10:35 – 12:20 Session II | ||
| 10:35 | Y. Mori | Invited Lecture 1: FAPI PET / Cancer stroma imaging – status quo and future perspectives |
| 11:20 | L. Joosten | OP05 New Radiolabeled Exendin Analogues Show Reduced Renal Retention |
| 11:32 | A. A. Hörmann | OP06 Influence of Peptide Length on the in Vitro and in Vivo Properties of 177Lu-labelled Gastrin Analogues |
| 11:44 | X. Guarrochena | OP07 Enhancing the in vivo stability of somatostatin-based radiotracers with the amide-to-triazole switch methodology. |
| 11:56 | C. Bolzati | OP08 [99mTc][Tc(N)(PNP)]-tagging of Biomolecules: Effects of the Introduction of Water-Soluble Substituents on the PNP Ligand Structure |
| 12:08 | N. Salvarese | OP09 [99mTc][Tc(N)PNP]-tagging of the Small RGDfK Peptide: Impact of Different PNP Structures on the Labeling and Pharmacokinetics of the Radioconjugates |
12:20 – Lunch
| 13:45 – 15:30 Session III | ||
| 13:45 | M. Ma | Invited Lecture 2: Coordination chemistry |
| 14:30 | E. Matazova | OP11 Benzoazacrown chelator BATA as a better candidate than DOTA for TAT with Bi(III) and Ac(III) |
| 14:42 | E. Goumi | OP12 Preclinical evaluation of [68Ga]Ga-DATA5m.SA.FAPi: A room temperature gallium-68 labeled radioligand for FAP targeting. |
| 14:54 | S. Ahenkorah | OP13 3p-C-NETA-TATE: A theranostic somatostatin analogue targeting neuroendocrine tumors |
| 15:06 | M. Asti | OP14 In Vivo stability and biodistribution of copper-64 labelled S-containing DOTA derivative: a potential chelator to thwart the biological instability of copper-based radiotracers |
| 15:18 | L. Zamurueva | OP15 Benzoazacrown ligands for a chelation of copper and lead radioisotopes and comparative stability of their complexes in vitro and in vivo |
15:30 – Coffee Break
| 16:00 – 18:00 Session IV | ||
| 16:00 | T.Main-Nock & R. Mansi | Invited Lecture 3 / debate: Agonists versus antagonists | Theodosia Maina-Nock (Athens, Greece) and Rosalba Mansi (Basel, Switzerland) |
| 16:45 | Poster Pitches | |
| 17:15 | Poster & Refreshments | |